首页> 外文期刊>Journal of drug delivery science and technology >Exploration of nanocrystal technology for the preparation of lovastatin immediate and sustained release tablets
【24h】

Exploration of nanocrystal technology for the preparation of lovastatin immediate and sustained release tablets

机译:纳米晶体技术探索洛伐他汀立即和持续释放片剂的制备

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to explore the feasibility of using nanocrystal technology for the design of immediate and sustained release tablets of poorly water soluble drugs. Nanocrystal aggregates comprised of lovastatin, a model drug, 20% PVP K17 and 5% SDS were prepared by spray drying. The nanocrystal aggregates were mixed with lactose, Avicel Ph 101 and Ac-Di-Sol?(blank granules) or 316 Fast Flo?lactose, MCC PH200, and Ac-Di-Sol?(direct compression), where the composition was optimized by uniform design. The blank granules adsorption method had superior flowability, filling and plastic deformation as well as rapid release rates, and the tableting process did not affect the release rate of nanocrystals. An optimized sustained release tablets formulation was also identified, which decreased the difference of drug release behavior under sink and non-sink conditions. In conclusion, nanocrystal technology is promising for preparing both immediate and sustained release tablets for poorly water soluble drugs with robust drug dissolution and release.
机译:本研究的目的是探讨利用纳米晶技术的可行性,以设计不良水溶性药物的即时和持续释放片剂。通过喷雾干燥制备由Lovastatin,模型药物,20%PVP K17和5%SDS组成的纳米晶体聚集体。将纳米晶体聚集体与乳糖,培养物pH101和AC-DI-SOL?(坯料颗粒)或316快速氟→乳糖,MCC pH200和AC-DI-SOL?(直接压缩)混合,其中组合物被优化统一的设计。空白颗粒吸附方法具有出色的流动性,填充和塑性变形以及快速释放速率,并且压片过程不影响纳米晶体的释放速率。还鉴定了优化的缓释片剂,其降低了下沉和非水槽条件下的药物释放行为的差异。总之,纳米晶体技术令人欣赏为具有稳健的药物溶解和释放的水溶性较差的药物直接和持续释放片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号